D.E. Shaw & Co
EWTX icon

D.E. Shaw & Co’s Edgewise Therapeutics EWTX Stock Holding History

D.E. Shaw & Co’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.3M Sell
104,863
-289,832
-73% -$8.36M ﹤0.01% 2505
2025
Q4 		$9.79M Sell
394,695
-282,866
-42% -$5.68M 0.01% 1773
2025
Q3 		$11M Buy
677,561
+82,129
+14% +$1.16M 0.01% 1603
2025
Q2 		$7.81M Buy
595,432
+454,884
+324% +$6.56M 0.01% 1685
2025
Q1 		$3.09M Sell
140,548
-545,823
-80% -$14.3M ﹤0.01% 2273
2024
Q4 		$18.3M Buy
686,371
+231,023
+51% +$7.36M 0.01% 1084
2024
Q3 		$12.2M Buy
455,348
+143,872
+46% +$2.86M 0.01% 1289
2024
Q2 		$5.61M Sell
311,476
-162,204
-34% -$2.83M 0.01% 1760
2024
Q1 		$8.64M Buy
473,680
+441,730
+1,383% +$7.02M 0.01% 1472
2023
Q4 		$350K Buy
+31,950
New +$224K ﹤0.01% 3681
2023
Q2 		– Sell
-24,736
Closed -$165K – 4324
2023
Q1 		$165K Buy
24,736
+13,462
+119% +$125K ﹤0.01% 3940
2022
Q4 		$101K Buy
+11,274
New +$106K ﹤0.01% 4362
2021
Q4 		– Sell
-13,695
Closed -$227K – 5489
2021
Q3 		$227K Sell
13,695
-32,472
-70% -$587K ﹤0.01% 4508
2021
Q2 		$985K Buy
+46,167
New +$1.26M ﹤0.01% 3555

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return